Structure of Candesantan Cilexetil CAS 145040 37 5 - Candesantan Cilexetil CAS 145040-37-5 Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

145040-37-5

Name

Can­desan­tan Cilex­etil

Syn­onyms

1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate [ACD/IUPAC Name] 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazol-7-carboxylat [Ger­man] [ACD/IUPAC Name] 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazol-7-carboxylat [Ger­man] 145040-37-5 [RN] 1H-Ben­z­im­i­­da­­zole-7-car­boxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester [ACD/​Index Name] 2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester 2-Éthoxy-1-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French] [ACD/IUPAC Name] 2-éthoxy-1-{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French] Can­desar­tan cilex­etil [JAN] [USAN] R85M2X0D68 UNII :R85M2X0D68 (±)-1-Hydrox­­yethyl 2-Ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate Cyclo­hexyl Car­bon­ate (Ester) (2-ethoxy-1-{[4-(2-(1H-1,2,3,4-tetraazol-5-yl)phenyl)phenyl]methyl}benzimidazol-7-ylcarbonyloxy)ethyl cyclo­hexy­loxy­for­mate [145040-37-5] 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethox 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2-(2h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate 1-(cyclohexyloxycarbonyloxy)ethyl 1-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate 1-cyclo­hexy­loxy­­car­bony­loxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1-cyclo­hexy­loxy­­car­bony­loxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1H-Ben­z­im­i­­da­­zoli­um, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)-, hydrox­ide, inner salt, (±)- 2-?ETHOXY-?1-?[[2′-?(2H-?TETRA­ZOL-?5-?YL)[1,?1′-?BIPHENYL]-?4-?YL]METHYL]-?1-?[[(CYCLO­HEXY­LOXY)CAR­BONYL]OXY]ETH­YL ESTER-?1H-?BEN­Z­IM­I­DA­ZOLE-?7-?CAR­BOXYLIC ACID 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Ben­z­im­i­­da­­zole-7-car­boxylic acid 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester 2-Ethoxy-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid [ACD/IUPAC Name] 2-Ethoxy-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclo­hexy­loxy­­car­bony­loxy-eth­yl ester 2-Ethoxy-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclo­hexy­loxy­­car­bony­loxy-eth­yl ester 7689-03-4 [RN] Amias [Trade name] Ata­cand [Trade name] Blo­press [Trade name] BR-75900 C077793 Camp­tothecine Can­desar­tan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester Can­desar­tan celex­etil can­desar­tan cilex­etil(?????????) CAN­DESAR­TAN CILEX­I­TIL DD6672500 H212/91 Ken­zen MFCD00871371 [MDL num­ber] Para­pres Phar­­makon1600-01504261 Racan­da Rat­a­cand [Trade name] TCV 116 | TCV116 TCV-116 ;TCV116 ;TCV 116;Atacand TCY 116 TL8000995

Mol­e­c­u­lar Structure

Structure of Candesantan Cilexetil CAS 145040 37 5 - Candesantan Cilexetil CAS 145040-37-5

Struc­ture of Can­desan­tan Cilex­etil CAS 145040-37-5

SMILES

CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5)C(=O)OC(C)OC(=O)OC6CCCCC6

Std­InChI

InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)

Std­InChIKey

GHOS­N­R­CGJF­B­JIB-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C33H34N6O6

Mol­e­c­u­lar Weight

610.66

MDL Number

MFCD00871371

Safe­ty Data

health hazard jpg - Candesantan Cilexetil CAS 145040-37-5environment jpg - Candesantan Cilexetil CAS 145040-37-5 GHS08, GHS09

Sig­nal Word

Warn­ing

Haz­ard Statements

H361-H400

Pre­cau­tion­ary Statements

P280

RIDADR

UN 3077 9 / PGI­II

WGK Germany

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Can­desan­tan Cilex­etil CAS 145040-37-5

Stan­dard

EP, USP

GMP

CFDA

Basic Patent Situation

US expiry date 20120604
EU expiry date 20110419 (20120428)
JP expiry date 20160428

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as Angiotensin II Recep­tor Antag­o­nist

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​c​a​n​d​e​s​a​n​t​a​n​-​c​i​l​e​x​e​t​i​l​-​c​a​s​-​1​4​5​0​4​0​-​3​7​-5/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the Cup.